U.S. Markets closed
  • S&P Futures

    3,856.00
    +11.00 (+0.29%)
     
  • Dow Futures

    31,148.00
    +52.00 (+0.17%)
     
  • Nasdaq Futures

    13,369.75
    +75.50 (+0.57%)
     
  • Russell 2000 Futures

    2,158.60
    +0.90 (+0.04%)
     
  • Crude Oil

    53.28
    +0.04 (+0.08%)
     
  • Gold

    1,870.30
    +3.80 (+0.20%)
     
  • Silver

    25.99
    +0.22 (+0.85%)
     
  • EUR/USD

    1.2137
    +0.0022 (+0.1821%)
     
  • 10-Yr Bond

    1.0900
    -0.0020 (-0.18%)
     
  • Vix

    21.58
    -1.66 (-7.14%)
     
  • GBP/USD

    1.3681
    +0.0026 (+0.1915%)
     
  • USD/JPY

    103.5150
    -0.0550 (-0.0531%)
     
  • BTC-USD

    34,364.58
    -298.03 (-0.86%)
     
  • CMC Crypto 200

    682.09
    -18.53 (-2.64%)
     
  • FTSE 100

    6,740.39
    +27.44 (+0.41%)
     
  • Nikkei 225

    28,727.48
    +204.22 (+0.72%)
     

Repligen Corp (RGEN) CFO Jon Snodgres Sold $757,845 of Shares

GuruFocus.com
·1 min read

- By insider

CFO of Repligen Corp (30-Year Financial, Insider Trades) Jon Snodgres (insider trades) sold 3,957 shares of RGEN on 01/04/2021 at an average price of $191.52 a share. The total sale was $757,845.


Repligen Corp is a bioprocessing company developing, producing and commercializing biologic drugs. The company offers its products to life science companies, global biopharmaceutical companies, and contract manufacturers worldwide. Repligen Corp has a market cap of $10.78 billion; its shares were traded at around $197.010000 with a P/E ratio of 240.24 and P/S ratio of 32.09. Repligen Corp had annual average EBITDA growth of 19.90% over the past five years. GuruFocus has detected 2 severe warning signs with Repligen Corp. .

CFO Recent Trades:

  • CFO Jon Snodgres sold 3,957 shares of RGEN stock on 01/04/2021 at the average price of $191.52. The price of the stock has increased by 2.87% since.

Directors and Officers Recent Trades:

  • Senior VP, R&D Ralf Kuriyel sold 435 shares of RGEN stock on 12/16/2020 at the average price of $186.18. The price of the stock has increased by 5.82% since.

For the complete insider trading history of RGEN, click here

.This article first appeared on GuruFocus.